The Impact of Hidradenitis Suppurativa on Families

Iltefat Hamzavi, MD, discusses the importance of support groups and other helpful resources for families and caregivers of patients with hidradenitis suppurativa and provides closing thoughts for clinical providers.

EP: 1.Signs and Symptoms of Hidradenitis Suppurativa (HS)

EP: 2.Epidemiology and Impact of Hidradenitis Suppurativa

EP: 3.The Pathophysiology of Hidradenitis Suppurativa

EP: 4.Differential Diagnosis When Considering Hidradenitis Suppurativa in a Patient

EP: 5.Overview of the Hurley Staging System for Hidradenitis Suppurativa

EP: 6.Comorbidities and Coordinating Care Between Specialists in Hidradenitis Suppurativa

EP: 7.Hidradenitis Suppurativa: Addressing the Psychosocial Impact and Hospitalization Rate

Now Viewing

EP: 8.The Impact of Hidradenitis Suppurativa on Families

EP: 9.Hidradenitis Suppurativa (HS): Staging Considerations and Unmet Needs

EP: 10.The Role of Treatment Guidelines for HS

EP: 11.Biologic Therapies for Hidradenitis Suppurativa

EP: 12.Recent Data on Bimekizumab for Hidradenitis Suppurativa

EP: 13.Ongoing Research in Hidradenitis Suppurativa

EP: 14.Managing Pain in Patients with Hidradenitis Suppurativa

EP: 15.The Role of Surgery in Hidradenitis Suppurativa

EP: 16.Optimizing Multidisciplinary Care of Patients with Hidradenitis Suppurativa

Video content above is prompted by the following question:

• The impact of HS can go beyond the patient. How can this disease also negatively impact families?

Related Videos

Related Content

Advertisement

December 16th 2024

FDA Approves Tapinarof Cream 1% for Patients With Atopic Dermatitis

Brooke McCormick

The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis.

November 21st 2024

Collaborating for Cancer Care Equity: Community and Academic Insights

Maggie L. Shaw

Coverage from the recent Institute for Value-Based Medicine event with NYU Langone Health.

September 25th 2024

Hidradenitis Suppurativa Disproportionately Affects Black, Female Patients

Brooke McCormick

A poster presented at the Skin of Color Update reported that hidradenitis suppurativa (HS) disproportionately affects Black patients, women, smokers, and those with public insurance or disabilities.

September 24th 2024

Semaglutide Improves Hidradenitis Suppurativa in Patients With Obesity

Cameron Santoro

Semaglutide treatment significantly improved quality of life and reduced flare-ups in patients with obesity and hidradenitis suppurativa.

September 17th 2024

Dermatologist Dissects Rosacea Diagnosis Challenges Among Patients of Color

Brooke McCormick

Hilary Baldwin, MD, FAAD, highlighted diagnostic complexities and shared treatment strategies for rosacea in patients with darker skin tones at the Skin of Color Update in New York City last Friday.

September 17th 2024

Expert Highlights Need for Greater Diversity in Dermatology Clinical Trials

Brooke McCormick

Valerie M. Harvey, MD, MPH, FAAD, founder of the Hampton Roads Center for Dermatology, highlighted the long-standing underrepresentation of minority populations in dermatology clinical trials at the Skin of Color Update 2024 in New York City on Friday.

Related Content

Advertisement

December 16th 2024

FDA Approves Tapinarof Cream 1% for Patients With Atopic Dermatitis

Brooke McCormick

The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis.

November 21st 2024

Collaborating for Cancer Care Equity: Community and Academic Insights

Maggie L. Shaw

Coverage from the recent Institute for Value-Based Medicine event with NYU Langone Health.

September 25th 2024

Hidradenitis Suppurativa Disproportionately Affects Black, Female Patients

Brooke McCormick

A poster presented at the Skin of Color Update reported that hidradenitis suppurativa (HS) disproportionately affects Black patients, women, smokers, and those with public insurance or disabilities.

September 24th 2024

Semaglutide Improves Hidradenitis Suppurativa in Patients With Obesity

Cameron Santoro

Semaglutide treatment significantly improved quality of life and reduced flare-ups in patients with obesity and hidradenitis suppurativa.

September 17th 2024

Dermatologist Dissects Rosacea Diagnosis Challenges Among Patients of Color

Brooke McCormick

Hilary Baldwin, MD, FAAD, highlighted diagnostic complexities and shared treatment strategies for rosacea in patients with darker skin tones at the Skin of Color Update in New York City last Friday.

September 17th 2024

Expert Highlights Need for Greater Diversity in Dermatology Clinical Trials

Brooke McCormick

Valerie M. Harvey, MD, MPH, FAAD, founder of the Hampton Roads Center for Dermatology, highlighted the long-standing underrepresentation of minority populations in dermatology clinical trials at the Skin of Color Update 2024 in New York City on Friday.